These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9371004)

  • 1. Menopause and the risk of thromboembolism.
    Galus M
    Am Fam Physician; 1997 Nov; 56(7):1723-4. PubMed ID: 9371004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risk of thromboembolism in contraception and hormone substitution: an update and recommendations].
    van den Brûle F; Gaspard U
    J Pharm Belg; 2004; 59(1):38-40. PubMed ID: 15129579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk of venous thromboembolism during postmenopausal hormone therapy].
    Pedersen AT; Ottesen B
    Ugeskr Laeger; 1996 Nov; 158(48):6923-4. PubMed ID: 8984757
    [No Abstract]   [Full Text] [Related]  

  • 4. Individualising hormone replacement therapy.
    Attilakos G; Wardle PG
    Practitioner; 2002 May; 246(1634):295-8, 302, 305 passim. PubMed ID: 12043347
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estrogen therapy and risk of thrombosis].
    Lakartidningen; 1997 Jul; 94(30-31):2664. PubMed ID: 9273430
    [No Abstract]   [Full Text] [Related]  

  • 6. Thromboembolic events secondary to estrogen therapy.
    Lee JR
    Am Fam Physician; 1998 May; 57(9):2071. PubMed ID: 9606299
    [No Abstract]   [Full Text] [Related]  

  • 7. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.
    Rexrode KM; Manson JE
    Circulation; 2007 Feb; 115(7):820-2. PubMed ID: 17309929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials].
    Arnesen H; Qvigstad E
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4064. PubMed ID: 9441436
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risk of venous thrombosis during postmenopausal estrogen therapy? The reporting system of adverse effects is functioning].
    Buajordet I; Dybwad TB
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2644-5. PubMed ID: 9324824
    [No Abstract]   [Full Text] [Related]  

  • 10. HRT and venous thromboembolism: more evidence of a link.
    Chen BH
    CMAJ; 2001 Jan; 164(1):87. PubMed ID: 11202677
    [No Abstract]   [Full Text] [Related]  

  • 11. [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].
    Hovelius B
    Lakartidningen; 2002 Jul; 99(28-29):3014-5. PubMed ID: 12170508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Only two secure indications left. Changing one's view of hormone replacement therapy].
    Fath R
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2236. PubMed ID: 14608994
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone replacement therapy and ischaemic heart disease: continuing questions but still no answers.
    Lloyd G
    Int J Clin Pract; 2000 Sep; 54(7):416-7. PubMed ID: 11070562
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The risk of venous thromboembolism in women during hormone replacement therapy].
    Zeltzer D; Shapira I; Berliner S
    Harefuah; 1999 Aug; 137(3-4):124-6. PubMed ID: 10959301
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risks and benefits of postmenopausal hormone replacement therapy].
    Szántó F
    Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER Study".
    Micheletti MC; Chevallier T
    Circulation; 2007 Sep; 116(13):e362; author reply e363. PubMed ID: 17893283
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone therapy and thromboembolic disease.
    Battaglioli T; Martinelli I
    Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hormone therapy and cardiovascular risk].
    Wütschert R; Cirafici P
    Praxis (Bern 1994); 2000 Jun; 89(25-26):1090-7. PubMed ID: 11367591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.